Yes, We Still Need IL-2 Receptor Antagonists.
Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC. fleminj@musc.edu.
J N
JN
Fleming
Department of Surgery, Medical University of South Carolina, Charleston, SC.|Department of Pharmacy, Ralph H Johnson VAMC, Charleston, SC.
D J
DJ
Taber
Transplant Center, Medical University of South Carolina, Charleston, SC.
N A
NA
Pilch
Department of Nephrology, Medical University of South Carolina, Charleston, SC.
T R
TR
Srinivas
Department of Surgery, Medical University of South Carolina, Charleston, SC.
K D
KD
Chavin
D000961:Antilymphocyte Serum; D006084:Graft Rejection; D015375:Receptors, Interleukin-2
D000961:Antilymphocyte Serum; D015375:Receptors, Interleukin-2
Immunosuppressant; editorial/personal viewpoint; fusion proteins and monoclonal antibodies: basiliximab/daclizumab; immunosuppressant; immunosuppressive regimens; induction; kidney transplantation/nephrology; polyclonal preparations: rabbit antithymocyte globulin